144 related articles for article (PubMed ID: 3602066)
1. [Simultaneous determination of disintegration and dissolution times of solid drug forms in a rotating flask dissolution tester. "Apparent" and "intrinsic" disintegration time].
Koch HP; Faltis I; Mladenow H
Pharmazie; 1987 Feb; 42(2):90-4. PubMed ID: 3602066
[TBL] [Abstract][Full Text] [Related]
2. [Drug liberation from floating capsules in the rotating-flask solubility tester].
Koch HP; Mertz M; Zinterhof G
Pharmazie; 1987 May; 42(5):312-5. PubMed ID: 3671440
[TBL] [Abstract][Full Text] [Related]
3. [In vitro studies of drug liberation from suppositories with the rotating flask method].
Koch HP; Klissenbauer C; Ritzinger A; Wallentin A
Pharmazie; 1987 Mar; 42(3):169-72. PubMed ID: 3602072
[TBL] [Abstract][Full Text] [Related]
4. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
Koch HP; Pfeifer G
Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
Koch HP; Alcorn G; Ritschel WA
Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
[TBL] [Abstract][Full Text] [Related]
6. Dissolution testing of orally disintegrating tablets.
Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
[TBL] [Abstract][Full Text] [Related]
7. [Determination and interpretation of in vitro solubility behavior of pharmaceutical agents. 2. The effect of surface tension of the dissolution medium on the liberation of drugs in commercial preparations (tablets, dragees)].
Bornschein M; Eitz K; Voigt R
Pharmazie; 1987 Feb; 42(2):83-6. PubMed ID: 3602064
[TBL] [Abstract][Full Text] [Related]
8. Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem.
Horkovics-Kovats S
J Pharm Sci; 2014 Feb; 103(2):456-64. PubMed ID: 24338791
[TBL] [Abstract][Full Text] [Related]
9. An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.
Laitinen R; Lahtinen J; Silfsten P; Vartiainen E; Jarho P; Ketolainen J
J Pharm Biomed Anal; 2010 Jun; 52(2):181-9. PubMed ID: 20116958
[TBL] [Abstract][Full Text] [Related]
10. Probability of passing dissolution acceptance criteria for an immediate release tablet.
Dumont ML; Berry MR; Nickerson B
J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
[TBL] [Abstract][Full Text] [Related]
11. The sound of tablets during coating erosion, disintegration, deaggregation and dissolution.
O'Mahoney N; Keating JJ; McSweeney S; Hill S; Lawrence S; Fitzpatrick D
Int J Pharm; 2020 Apr; 580():119216. PubMed ID: 32165222
[TBL] [Abstract][Full Text] [Related]
12. Oral Solid Dosage Form Disintegration Testing - The Forgotten Test.
Al-Gousous J; Langguth P
J Pharm Sci; 2015 Sep; 104(9):2664-75. PubMed ID: 25546430
[TBL] [Abstract][Full Text] [Related]
13. Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation.
Horkovics-Kovats S; Brunovský P; Pichler A; Bulitta JB
Eur J Pharm Sci; 2015 Oct; 78():245-54. PubMed ID: 26215465
[TBL] [Abstract][Full Text] [Related]
14. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.
Brockmeier D; von Hattingberg HM
Arzneimittelforschung; 1982; 32(3):248-51. PubMed ID: 6896279
[TBL] [Abstract][Full Text] [Related]
15. Alternative and generalized approach to in vitro-in vivo correlation.
Vitková Z; Vitko A; Zabka M; Cizmárik J
Acta Pol Pharm; 2011; 68(3):417-21. PubMed ID: 21648197
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
[TBL] [Abstract][Full Text] [Related]
17. Salt formation to improve drug solubility.
Serajuddin AT
Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
[TBL] [Abstract][Full Text] [Related]
18. Dissolution or disintegration - substitution of dissolution by disintegration testing for a fixed dose combination product.
Grube A; Gerlitzki C; Brendel M
Drug Dev Ind Pharm; 2019 Jan; 45(1):130-138. PubMed ID: 30230388
[TBL] [Abstract][Full Text] [Related]
19. Miniaturized INtrinsic DISsolution Screening (MINDISS) assay for preformulation.
Alsenz J; Haenel E; Anedda A; Du Castel P; Cirelli G
Eur J Pharm Sci; 2016 May; 87():3-13. PubMed ID: 26360839
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the disintegration of tablets in biorelevant media.
Anwar S; Fell JT; Dickinson PA
Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
